Atlas Trials

Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis

Clinical trial NCT01517282 · COMPLETED

Trial details

NCT number
NCT01517282
Sponsor
MorphoSys AG
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2012-01-01
Primary completion
2014-01-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.